Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Cambridge Nutritional Sciences (FRA:RVKA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Cambridge Nutritional Sciences's EV-to-EBIT for today is
Cambridge Nutritional Sciences's current Enterprise Value is €0.94 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 was €1.67 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Cambridge Nutritional Sciences's EV-to-EBITDA for today is:
Cambridge Nutritional Sciences's current Enterprise Value is €0.94 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was €2.41 Mil.
Cambridge Nutritional Sciences's current Enterprise Value is €0.94 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's Revenue for the trailing twelve months (TTM) ended in Sep. 2025 was €9.46 Mil.
Cambridge Nutritional Sciences's current Enterprise Value is €0.94 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2025 was €-0.29 Mil.
Cambridge Nutritional Sciences's current Enterprise Value is €0.94 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was €-0.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Nutritional Sciences Enterprise Value Related Terms
Cambridge Nutritional Sciences Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Nutritional Sciences Enterprise Value Chart
FRA:RVKA vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Nutritional Sciences Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Cambridge Nutritional Sciences's Enterprise Value falls into.
Cambridge Nutritional Sciences Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Nutritional Sciences (FRA:RVKA) has a Enterprise Value of €0.94 Mil as of Jun. 30, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Cambridge Nutritional Sciences and its competitors.
Is Cambridge Nutritional Sciences' Enterprise Value too high?
Cambridge Nutritional Sciences' current Enterprise Value is €0.94 Mil.
How does Cambridge Nutritional Sciences' Enterprise Value compare to ISRG and BDX?
Cambridge Nutritional Sciences' Enterprise Value of €0.94 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Cambridge Nutritional Sciences and its competitors. Cambridge Nutritional Sciences's current Enterprise Value is €0.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Cambridge Nutritional Sciences (FRA:RVKA) has a current Enterprise Value of €0.94 Mil. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 32.5% below its estimated fair value. The current Enterprise Value is €0.94 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current Enterprise Value is €0.94 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cambridge Nutritional Sciences Business Description
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RVKA has been successfully added to your 